20% of survey complete.

Please take 2 minutes to answer a few short questions relating to the FDA's Revised Draft Guidance for Industry on Distributing Scientific and Medical Publications on Unapproved New Uses—Recommended Practices.

For some background on this topic, see "WLF to FDA: See You in Court!," as well as FDA's Guidance document, and the introduction on page 3 of this survey.

Results of this survey (including comments) may be summarized in an issue of Pharma Marketing News.

Your comments are confidential (anonymous) unless you specifically provide your contact information at the end of the survey and allow us to attribute comments to you personally.

After completion of the survey, you will be able to view the de-identified summary of results (comments not included) to date.